| Primary |
| Induction Of Anaesthesia |
18.2% |
| Product Used For Unknown Indication |
18.2% |
| Preoperative Care |
15.2% |
| Caesarean Section |
12.1% |
| Postoperative Care |
12.1% |
| Biopsy Lymph Gland |
3.0% |
| Drug Administration Error |
3.0% |
| Infection Prophylaxis |
3.0% |
| Knee Arthroplasty |
3.0% |
| Parainfluenzae Virus Infection |
3.0% |
| Prolonged Rupture Of Membranes |
3.0% |
| Therapeutic Skin Care Topical |
3.0% |
| Tooth Extraction |
3.0% |
|
| Anaphylactic Reaction |
18.5% |
| Circulatory Collapse |
7.4% |
| Rash Pruritic |
7.4% |
| Syncope |
7.4% |
| Anaphylactic Shock |
3.7% |
| Cardiac Arrest |
3.7% |
| Chemical Injury |
3.7% |
| Dermatitis Allergic |
3.7% |
| Drug Hypersensitivity |
3.7% |
| Headache |
3.7% |
| Hypotension |
3.7% |
| Hypoxic-ischaemic Encephalopathy |
3.7% |
| Immunology Test Abnormal |
3.7% |
| Maternal Exposure During Delivery |
3.7% |
| Occupational Asthma |
3.7% |
| Occupational Exposure To Product |
3.7% |
| Oedema |
3.7% |
| Paraplegia |
3.7% |
| Parotid Gland Enlargement |
3.7% |
| Rash |
3.7% |
|
| Secondary |
| Systemic Lupus Erythematosus |
19.3% |
| Induction Of Anaesthesia |
15.6% |
| Product Used For Unknown Indication |
15.6% |
| Postoperative Care |
10.4% |
| Surgery |
6.7% |
| Anaesthesia |
5.9% |
| Prophylaxis |
4.4% |
| General Anaesthesia |
3.7% |
| Infection Prophylaxis |
3.7% |
| Acanthamoeba Keratitis |
3.0% |
| Keratitis Fungal |
2.2% |
| Pain |
2.2% |
| Essential Hypertension |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Antibiotic Prophylaxis |
0.7% |
| Breast Cancer |
0.7% |
| Contraception |
0.7% |
| Excessive Daytime Sleepiness |
0.7% |
| Hypertension |
0.7% |
| Local Anaesthesia |
0.7% |
|
| Teratogenicity |
26.5% |
| Tachycardia |
20.6% |
| Anaphylactic Reaction |
8.8% |
| Urticaria |
5.9% |
| Blood Pressure Abnormal |
2.9% |
| Cardiac Arrest |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Endophthalmitis |
2.9% |
| Keratitis |
2.9% |
| Pemphigoid |
2.9% |
| Swollen Tongue |
2.9% |
| Throat Irritation |
2.9% |
| Tooth Discolouration |
2.9% |
| Tremor |
2.9% |
| Type I Hypersensitivity |
2.9% |
| Type Iv Hypersensitivity Reaction |
2.9% |
| Urinary Tract Infection |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.3% |
| Drug Use For Unknown Indication |
7.5% |
| Prophylaxis |
6.0% |
| Pain |
5.0% |
| Acute Lymphocytic Leukaemia |
4.3% |
| Nausea |
4.0% |
| Hypertension |
3.7% |
| Diffuse Large B-cell Lymphoma |
3.6% |
| Infection |
3.0% |
| Acute Myeloid Leukaemia |
2.8% |
| Constipation |
2.5% |
| Plasma Cell Myeloma |
2.3% |
| Anxiety |
2.1% |
| Depression |
2.1% |
| Metastases To Bone |
2.1% |
| Multiple Myeloma |
2.1% |
| Breast Cancer |
1.9% |
| Prostate Cancer |
1.9% |
| B-cell Lymphoma |
1.9% |
| Neoplasm Malignant |
1.7% |
|
| Weight Decreased |
13.5% |
| Vomiting |
8.8% |
| Renal Failure Acute |
8.1% |
| Vision Blurred |
6.8% |
| Respiratory Failure |
6.1% |
| Osteonecrosis Of Jaw |
5.4% |
| Rash |
5.4% |
| Tooth Extraction |
4.7% |
| Stomatitis |
4.1% |
| Thrombocytopenia |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Febrile Neutropenia |
3.4% |
| Pneumonia |
3.4% |
| Post Procedural Haematoma |
3.4% |
| Rash Generalised |
3.4% |
| Sepsis |
3.4% |
| Septic Shock |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| International Normalised Ratio Increased |
2.7% |
| Platelet Count Decreased |
2.7% |
|
